van Muijen, M. E.
van der Schoot, L. S. http://orcid.org/0000-0002-4127-1187
van den Reek, J. M. P. A.
de Jong, E. M. G. J.
Article History
Received: 6 April 2021
Revised: 11 August 2021
Accepted: 20 August 2021
First Online: 31 August 2021
Declarations
:
: ME van Muijen carries out clinical trials for Abbvie, Celgene, Janssen and Novartis, and has received speaking fees from Janssen. All funding is not personal but goes to the independent Research Fund of the Department of Dermatology of the Radboud University Medical Center Nijmegen (Radboudumc), The Netherlands. LS van der Schoot carries out clinical trials for Janssen and Novartis. All funding is not personal but goes to the independent Research Fund of the Department of Dermatology of the Radboud University Medical Center Nijmegen (Radboudumc), The Netherlands. JMPA van den Reek carries out clinical trials for AbbVie, Celgene and Janssen and has received speaking fees/attended advisory boards from AbbVie, Janssen, BMS, Almirall, LEO Pharma and Eli Lilly and reimbursement for attending symposiums from Janssen, Pfizer, Celgene and AbbVie. All funding is not personal but goes to the independent research fund of the department of dermatology of Radboud University Medical Center Nijmegen (Radboudumc), The Netherlands. EMGJ de Jong has received research grants for the independent research fund of the department of dermatology of the Radboud University Medical Center Nijmegen, The Netherlands from AbbVie, Pfizer, Novartis, Janssen Pharmaceuticals and Leo Pharma and has acted as consultant and/or paid speaker for and/or participated in research sponsored by companies that manufacture drugs used for the treatment of psoriasis including AbbVie, Janssen Pharmaceutica, Novartis, Lily, Celgene, Leo Pharma, UCB and Almirall. All funding is not personal but goes to the independent research fund of the department of dermatology of Radboud University Medical Center Nijmegen (Radboudumc), The Netherlands.
: This study was reviewed by the ethics committee of the region of Arnhem-Nijmegen and Radboud University Medical Center and was deemed to not fall within the remit of the Medical Research Involving Human Subjects Act (2021-13093), as no personal data was collected. Therefore, informed consent from participants was not mandatory. The study was conducted in accordance with the ethical principles of the Declaration of Helsinki.
: Consent to participate was assumed in case of completion of the e-survey. No personal data was collected.
: Not applicable.